Biomarkers of Alzheimer’s Disease: An Overview of the Recent Inventions

ISSN: 2210-3104 (Online)
ISSN: 2210-3090 (Print)

Volume 6, 2 Issues, 2016

Download PDF Flyer

Recent Patents on Biomarkers

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Biomarkers of Alzheimer’s Disease: An Overview of the Recent Inventions

Recent Patents on Biomarkers, 3(3): 183-187.

Author(s): Obulesu Magisetty, Jhansilakshmi Magisetty, Dhanalakshmi Magisetty and Lakshmi Magisetty.

Affiliation: Department of Materials Science, Graduate School of Pure and Applied Sciences, Tsukuba University, Tsukuba, Ibaraki 305-8573, Japan.


The etiology of Alzheimer’s disease (AD) is complex which includes oxidative stress, apoptosis, mutations in genes, imbalance in metal homeostasis and neuroinflammation. Biomarkers such as micro RNAs, peptides, protein complexes and genes in various body fluids of AD patients play a pivotal role not only in diagnosis of the disease but also in following the therapeutic effects of drugs employed to treat this neurodegenerative disorder. However, there has been a substantial dearth in diagnosing this disease at the earliest. This review focuses on recent advances and patents in the field of biomarkers of AD. It strongly emphasizes the growing need to translate the available and upcoming knowledge into substantial clinical trials to streamline a vital armamentarium for the disease.


Alzheimer’s disease, biochips, biomarker, genes, miRNA, protein complex.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 3
Issue Number: 3
First Page: 183
Last Page: 187
Page Count: 5
DOI: 10.2174/22103090113036660008
Global Biotechnology Congress 2016Drug Discovery and Therapy World Congress 2016

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science